Animal models of sudden unexplained death

FEMS Immunology and Medical Microbiology

Volumn 42, Issue 1, 2004, Pages 34-41

  Blood Siegfried, Jane ^a   Shelton, Burton ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Immune development; Inflammation; SIDS

Indexed keywords

NICOTINE; TOXIN;

AGE DISTRIBUTION; ANIMAL MODEL; APNEA; HUMAN; HYPOXIA; INFECTION; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; SHORT SURVEY; SUDDEN INFANT DEATH SYNDROME;

ANIMALS; CHICK EMBRYO; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY; INFANT; INFECTION; INFLAMMATION; RABBITS; RATS; SUDDEN INFANT DEATH;

EID: 4344615957     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2004.06.009     Document Type: Short Survey

References (76)

1. Blackwell C.C., Weir D.M. The role of infection in sudden infant death syndrome. FEMS Immunol. Med. Microbiol. 25:1999;1-6
2. Willinger M., James L.S., Catz C. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatr. Pathol. 11:1991;677-684
3. Siarakas S., Damas E., Murrell W.G. Is cardiorespiratory failure induced by bacterial toxins the cause of sudden infant death syndrome? Studies with an animal model (the rabbit). Toxicon. 33:1995;635-649
4. Pickering L.K., Snyder J.D. Gastroenteritis. Behrman R.E., Kliegman R.M., Jenson H.B. Nelson Textbook of Pediatrics. 2000;765-768 W.B. Saunders, Philadelphia, PA
5. Kulangara A.C., Schechtman A.M. Passage of heterologous serum proteins from mother to foetal compartments in the rabbit. Am. J. Physiol. 203:1962;1071-1080
6. Siarakas S., Damas E., Murrell W.G. The effect of enteric bacterial toxins on the catecholamine levels of the rabbit. Pathology. 29:1997;278-285
7. Morris J.A. The common bacterial toxins hypothesis of sudden infant death syndrome. FEMS Immunol. Med. Microbiol. 25:1999;11-17
8. Zorgani A., Essery S.D., Al Madani O., Bentley A.J., James V.S., MacKenzie D.A.C., Keeling J.W., Rambaud C., Hilton J., Blackwell C.C., Weir D.M., Busuttil A. Detection of pyrogenic toxins of Staphylococcus aureus in sudden infant death syndrome. FEMS Immunol. Med. Microbiol. 25:1999;103-108
9. Blackwell C.C., Gordon A.E., James V.S., MacKenzie D.A.C., Mogensen-Buchanan M., el Ahmer O.R., Al Madani O., Toro K., Csukas Z., Sotonyi P., Weir D.M., Busuttil A. The role of bacterial toxins in sudden infant death syndrome (SIDS). Int. J. Med. Microbiol. 291:2002;561-570
10. Harrison L.M., Morris J.A., Telford D.R., Brown S.M., Jones K. The nasopharyngeal bacterial flora in infancy: effects of age, gender, season, viral upper respiratory tract infection and sleeping position. FEMS Immunol. Med. Microbiol. 25:1999;19-28
11. Rambaud C., Guibert M., Briand E., Grangeot-Keros L., Coulomb-L'Herminé A., Dehan M. Microbiology in sudden infant death syndrome (SIDS) and other childhood deaths. FEMS Immunol. Med. Microbiol. 25:1999;59-65
12. Lee S., Barson A.J., Drucker D.B., Morris J.A., Telford D.R. Lethal challenge of gnotobiotic weanling rats with bacterial isolates from cases of sudden infant death syndrome (SIDS). J. Clin. Pathol. 40:1987;1393-1396
13. Wilson C.E. Sudden infant death syndrome and Canadian Aboriginals: bacteria and infections. FEMS Immunol. Med. Microbiol. 25:1999;221-226
14. Morris J.A., Haran D., Smith A. Hypothesis: common bacterial toxins are a possible cause of the sudden infant death syndrome. Med. Hypotheses. 22:1987;211-222
15. Jakeman K.J., Rushton D.I., Smith H., Sweet C. Exacerbation of bacterial toxicity to infant ferrets by influenza virus: possible role in sudden infant death syndrome. J. Infect. Dis. 163:1991;35-40
16. Lundemose J.B., Smith H., Sweet C. Cytokine release from human peripheral blood leucocytes incubated with endotoxin with and without prior infection with influenza virus: relevance to the sudden infant death syndrome. Int. J. Exp. Pathol. 74:1993;291-297
17. Ariagno R.L. Apnea. Behrman R.E. Nelson Updates. 1994;1-12 W.B. Saunders, Philadelphia, PA
18. Guntheroth W.G. Sudden infant death syndrome (crib death). Am. Heart J. 93:1977;784-793
19. Guntheroth W.G. Interleukin-1 as intermediary causing prolonged sleep apnea and SIDS during respiratory infections. Med. Hypotheses. 28:1989;121-123
20. Pattison C.P., Marshall B.J., Scott L.W., Herndon B., Willsie S.K. Proposed link between Helicobacter pylori (HP) and sudden infant death syndrome (SIDS): possible pathogenic mechanisms in an animal model. I. Effects of intratracheal urease. Gastroenterol. 114:1998;A900
21. Pattison C.P., Scott L.W., Herndon B., Willsie S.K. Proposed link between Helicobacter pylori (HP) and sudden infant death syndrome (SIDS): possible pathogenic mechanisms in an animal model. II. Effects of intratracheal urease after pretreatment with intravenous IL-1 beta. Gastroenterol. 114:1998;A900
22. Elitsur Y. Helicobacter pylori and SIDS: the jury is in at last! Am. J. Gastroenterol. 97:2002;1576-1577
23. Ho G.Y., Windsor H.M., Snowball B., Marshall B.J. Helicobacter pylori is not the cause of sudden infant death syndrome (SIDS). Am. J. Gastroenterol. 96:2001;3288-3294
24. Blair P.S., Fleming P.J., Bensley D., Smith I., Bacon C., Taylor E., Berry J., Golding J., Tripp J. Smoking and the sudden infant death syndrome: results from 1993-5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Confidential Enquiry into Stillbirths and Deaths Regional Coordinators and Researchers. BMJ. 313:1996;195-198
25. Alm B., Milerad J., Wennergren G., Skjaerven R., Oyen N., Norvenius G., Daltveit A.K., Helweg-Larsen K., Markestad T., Irgens L.M. A case-control study of smoking and sudden infant death syndrome in the Scandinavian countries 1992-1995. The Nordic Epidemiological SIDS Study. Arch. Dis. Child. 78:1998;329-334
26. Klonoff-Cohen H.S., Edelstein S.L., Lefkowitz E.S., Srinivasan I.P., Kaegi D., Chang J.C., Wiley K.J. The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. JAMA. 273:1995;795-798
27. MacDorman M.F., Cnattingius S., Hoffman H.J., Kramer M.S., Haglund B. Sudden infant death syndrome and smoking in the United States and Sweden. Am.J. Epidemiol. 146:1997;249-257
28. Fainstein V., Musher D.M. Bacterial adherence to pharyngeal cells in smokers, non-smokers, and chronic bronchitis. Infect. Immun. 26:1979;178-182
29. Hofhuis W., de Jongste J.C., Merkus P.J.F.M. Adverse health effects of prenatal and postnatal tobacco smoke exposure on children. Arch. Dis. Child. 88:2003;1086-1090
30. Strachan D.P., Cook D.G. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 52:1997;905-914
31. Gurkan F., Kiral A., Dagli E., Karakoc F. The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis. Eur. J. Epidemiol. 16:2000;465-468
32. Lanari M., Giovannini M., Giuffre L., Marini A., Rondini G., Rossi G.A., Merolla R., Zuccotti G.V., Salvioli G.P. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Pediatr. Pulmonol. 33:2002;458-465
33. Drucker D.B., Aluyi H.S., Morris J.A., Telford D.R., Gibbs A. Lethal synergistic action of toxins of bacteria isolated from sudden infant death syndrome. J. Clin. Pathol. 45:1992;799-801
34. Sayers N.M., Drucker D.B., Morris J.A., Telford D.R. Lethal synergy between toxins of staphylococci and enterobacteria: implications for sudden infant death syndrome. J. Clin. Pathol. 48:1995;929-932
35. Sayers N.M., Drucker D.B., Morris J.A., Telford D.R. Significance of endotoxin in lethal synergy between bacteria associated with sudden infant death syndrome: follow-up study. J. Clin. Pathol. 49:1996;365-368
36. Sayers N.M., Drucker D.B., Telford D.R., Morris J.A. Effects of nicotine on bacterial toxins associated with cot death. Arch. Dis. Child. 73:1995;549-551
37. Sayers N.M., Drucker D.B. Animal models used to test the interactions between infectious agents and products of cigarette smoked implicated in sudden infant death syndrome. FEMS Immunol. Med. Microbiol. 25:1999;115-123
38. Raza M.W., Essery S.D., Elton R.A., Weir D.M., Busuttil A., Blackwell C.C. Exposure to cigarette smoke, a major risk factor for sudden infant death syndrome: effects of cigarette smoke on inflammatory responses to viral infection and bacterial toxins. FEMS Immunol. Med. Microbiol. 25:1999;145-154
39. Hakki A., Friedman H., Pross S. Nicotine modulation of apoptosis in human coronary artery endothelial cells. Int. Immunopharmacol. 2:2002;1403-1409
40. Slotkin T.A., Saleh J.L., McCook E.C., Seidler F.J. Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for sudden infant death syndrome. Teratology. 55:1997;177-184
41. St. John W.M., Leiter J.C. Maternal nicotine depresses eupneic ventilation of neonatal rats. Neurosci. Lett. 267:1999;206-208
42. Froen T.F., Aker H., Stray-Pedersen B., Saugstad O.D. Adverse effects of nicotine and interleukin-1 beta on autoresuscitation after apnea in piglets: implications for sudden infant death syndrome. Pediatrics. 105:2000
43. Froen J.F., Amerio G., Stray-Pedersen B., Saugstad O.D. Detrimental effects of nicotine and endotoxin in the newborn piglet brain during severe hypoxemia. Biol. Neonate. 82:2002;188-196
44. Blood-Siegfried J., Nyska A., Lieder H., Joe M., Vega L., Patterson R., Germolec D. Synergistic effect of influenza a virus on endotoxin-induced mortality in rat pups: a potential model for sudden infant death syndrome. Pediatr. Res. 52:2002;481-490
45. Lodemore M.R., Petersen S.A., Wailoo M.P. Factors affecting the development of night time temperature rhythms. Arch. Dis. Child. 67:1992;1259-1261
46. Gordon A.E., Al Madani O., Weir D.M., Busuttil A., Blackwell C.C. Cortisol levels and control of inflammatory responses to toxic shock syndrome toxin-1 (TSST-1): the prevalence of night-time deaths in sudden infant death syndrome (SIDS). FEMS Immunol. Med. Microbiol. 25:1999;199-206
47. Pollmacher T., Mullington J., Korth C., Schreiber W., Hermann D., Orth A., Galanos C., Holsboer F. Diurnal variations in the human rest response to endotoxin. J. Infect. Dis. 174:1996;1040-1045
48. Entzian P., Linnemann K., Schlaak M., Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am. J. Respir. Crit. Care Med. 153:1996;1080-1086
49. Hassan J., Reen D.J. T-cell function in the human newborn. Immunol. Today. 21:2000;107-108
50. Solomon J.B. Foetal and neonatal immunology. Neuberger A, Tatum E.L. Frontiers of Biology. 1971;1-363 North-Holland, Amsterdam
51. Adkins B., Hamilton K. Freshly isolated-4 murine neonatal T cells produce IL in response to anti-CD3 stimulation. J. Immunol. 149:1992;3448-3455
52. Sarzotti M., Robbins D.S., Hoffman P.M. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science. 271:1996;1726-1728
53. Schelonka R.L., Dimmitt R.A., Kahled M., Tanner J., Schroeder H.W. Limiting T and B cell receptor CDR3 diversity alters immune responsiveness to bacterial antigens. Pediatr. Res. 53:2003;16A
54. Gehrs B.C., Riddle M.M., Williams W.C., Smialowicz R.J. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: II. Effects on the pup and the adult. Toxicology. 122:1997;229-240
55. de Bont E.S., Martens A., van Raan J., Samson G., Fetter W.P., Okken A., de Leij L.H., Kimpen J.L. Diagnostic value of plasma levels of tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) in newborns with sepsis. Acta Paediatr. 83:1994;696-699
56. Groll A.H., Meiser A., Weise M., Rettwitz-Volk W., von Loewenich V., Gussetis E.S., Kornhuber B. Interleukin 6 as early mediator in neonatal sepsis. Pediatr. Infect. Dis. J. 11:1992;496-498
57. Girardin E.P., Berner M.E., Grau G.E., Suter S., Lacourt G., Paunier L. Serum tumour necrosis factor in newborns at risk for infections. Eur. J. Pediatr. 149:1990;645-647
58. Atici A., Satar M., Alparslan N. Serum interleukin-1 beta in neonatal sepsis. Acta Paediatr. 85:1996;371-374
59. Cai Z.W., Pan Z.L., Pang Y., Evans O.B., Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr. Res. 47:2000;64-72
60. Hagberg H., Gilland E., Bona E., Hanson L.A., HahnZoric M., Blennow M., Holst M., McRae A., Soder O. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr. Res. 40:1996;603-609
61. Matsuda K., Tsutsumi H., Okamoto Y., Chiba C. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin. Diagn. Lab. Immunol. 2:1995;322-324
62. Tsutsumi H., Matsuda K., Sone S., Takeuchi R., Chiba S. Respiratory syncytial virus-induced cytokine production by neonatal macrophages. Clin. Exp. Immunol. 106:1996;442-446
63. Butler J.E. Immunologic aspects of breast feeding, antiinfectious activity of breast milk. Semin. Perinatol. 3:1979;255-270
64. Binaghi R.A., Oettgen H.F., Benacerraf B. Anaphylactic antibody in the young rat. Int. Arch. Aller. Appl. Immunol. 29:1966;105-111
65. Quie P.G. Antimicrobial defenses in the neonate. Semin. Perinatol. 14:1990;2-9
66. Morris J.F., Hoyer J.T., Pierce S.K. Antigen presentation for T cell interleukin-2 secretion is a late acquisition of neonatal B cells. Eur. J. Immunol. 22:1992;2923-2928
67. McGhee J.R., Michalek S.M., Ghanta V.K. Rat immunoglobulins in serum and secretions: purification of rat IgM, IgA and IgG and their quantitation in serum, colostrum, milk and saliva. Immunochemistry. 12:1975;817-823
68. Fillastre C., Guerin N., Ajjan N., Triau R. 20 years' use of the diphtheria-pertussis-tetanus vaccine. Pediatrie. 43:1988;73-79
69. Fadel S., Sarzotti M. Cellular immune responses in neonates. Int. Rev. Immunol. 19:2000;173-193
70. Wilson C.B., Penix L., Melvin A., Lewis D.B. Lymphokine regulation and the role of abnormal regulation in immunodeficiency. Clin. Immunol. Immunopathol. 67:1993;S25-S32
71. Burchett S.K., Corey L., Mohan K.M., Westall J., Ashley R., Wilson C.B. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J. Infect. Dis. 165:1992;813-818
72. Vetro S.W., Bellanti J.A. Fetal and neonatal immunoincompetence. Fetal Ther. 4(Suppl. 1):1989;82-91
73. Wilson C.B., Lewis D.B., English B.K. T cell development in the fetus and neonate. Adv. Exp. Med. Biol. 310:1991;17-27
74. Mosier D.E., Cohen P.L. Ontogeny of mouse T-lymphocyte function. Fed. Proc. 34:1975;137-140
75. Marshall-Clarke S., Reen D., Tasker L., Hassan J. Neonatal immunity: how well has it grown up? Immunol. Today. 21:2000;35-41
76. Griffioen A.W., Toebes E.A., Zegers B.J., Rijkers G.T. Role of CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide. Cell Immunol. 143:1992;11-22